top of page

 
業績|論文・出版物|目次|ALL
 

Dendritic cells transduced with gp100 gene by RGD fiber-mutant adenovirus vectors are highly efficacious in generating anti-B16BL6 melanoma immunity in mice

Okada N., Masunaga Y., Okada Y., Mizuguchi H., Iiyama S., Mori N., Sasaki A., Nakagawa S., Mayumi T., Hayakawa T., Fujita T., Yamamoto A.

Gene Ther., 10, 1891-1902 (2003)

Vanadate enhances leptin-induced activation of JAK/STAT pathway in CHO cells

Kita A., Uotani S., Kuwahara H., Takahashi R., Oshima K., Yamasaki H., Mizuguchi H., Hayakawa T., Nagayama Y., Yamaguchi Y., Eguchi K.

Biochem. Biophys. Res. Commun., 302, 805-809 (2003)

Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice

Li Y., Takemura G., Kosai K.I., Yuge K., Nagano S., Esaki M., Goto K., Takahashi T., Hayakawa K., Koda M., Kawase Y., Maruyama R., Okada H., Minatoguchi S., Mizuguchi H., Fujiwara T., Fujiwara H.

Circulation, 107, 2499-2506 (2003)

Thyroid cancer immuno-therapy with retroviral and adenoviral vectors expressing granulocyte macrophage colony stimulating factor and interleukin-12 in a rat model

Tanaka K., Towata S., Nakao K., Mizuguchi H., Hayakawa T., Niwa M., Ishii N., Nagayama Y.

Clin. Endocrinol., 59, 734-742 (2003)

Prevention of autoantibody-mediated Graves'-like hyperthyroidism in mice with IL-4, a Th2 cytokine

Nagayama Y, Mizuguchi H., Hayakawa T., Niwa M., McLachlan SM., Rapoport B.

J. Immunol., 170, 3522-3527 (2003)

Enhanced antitumor effect of combined replicative adenovirus and nonreplicative adenovirus expressing interleukin-12 in an immunocompetent mouse model

Nagayama Y., Nakao, K., Mizuguchi H., Hayakawa T., Niwa M.

Gene Ther., 10, 1400-1403 (2003)

Role of H1-calponin in pancreatic AR42J cell differentiation into insulin-producing cells

Morioka T., Koyama H., Yamamura H., Tanaka S., Fujimoto, S., Emoto M., Mizuguchi H., Hayakawa T., Kojima I., Takahashi K., Nishizawa Y.

Diabetes, 52, 760-766 (2003)

A novel T7 system utilizing mRNA coding for T7 RNA polymerase

Nakano R., Nakagawa T., Imazu S., Katayama K., Mizuguchi H., Hayakawa T., Tsutsumi Y., Nakagawa S., Mayumi T.

Biochem. Biophys. Res. Commun., 301, 974-978 (2003)

Gene transduction efficiency and maturation status in mouse bone marrow-derived dendritic cells infected with conventional or RGD fiber-mutant adenovirus vectors

Okada N., Masunaga Y., Okada Y., Iiyama S., Tsuda T., Matsubara A., Mori N., Mizuguchi H., Hayakawa T., Fujita T., Yamamoto A.

Cancer Gene Ther., 10, 421-431 (2003)

A novel PPAR gamma gene therapy to control inflammation associated with inflammatory bowel disease in a murine model

Katayama K., Wada K., Nakajima A., Yoshida S., Mizuguchi H., Hayakawa T., Nakagawa S., Kadowaki T, Nagai R., Kamisaki Y, Blumberg RS., Mayumi T.

Gastroenterology, 124, 1315-1324 (2003)

An investigation of adverse effects caused by the injection of high-dose TNFα-expressing adenovirus vector into established murine melanoma

Okada Y., Okada N., Mizuguchi H., Hayakawa T., Mayumi T., Mizuno N.

Gene Ther., 10, 700-705 (2003)

In vivo expression of B:9-23 peptide/I-Ag7 complex may abrogate the inhibition of diabetes induced by RGD-fiber-mutant adenovirus in NOD mice

Abiru N., Sun F., Kawasaki E., Yamasaki H., Oshima K., Nagayama Y., Mizuguchi H., Hayakawa T., Miao D., Liu E., Eisenbarth G.S., Eguchi K.

Annals N.Y. Acad. Sci., 1005, 218-221 (2003)

Long-term hematopoietic stem cells require stromal cell-derived factor-1 for colonizing bone marrow during ontogeny

Ara T., Tokoyoda K., Sugiyama T., Egawa T., Kawabata K., Nagasawa T.

Immunity, 19, 257-267 (2003)

A role of CXC chemokine ligand 12/stromal cell-derived factor-1/pre-B cell growth stimulating factor and its receptor CXCR4 in fetal and adult T cell development in vivo

Ara T., Itoi M., Kawabata K., Egawa T., Tokoyoda K., Sugiyama T., Fujii N., Amagai T., Nagasawa T.

J. Immunol., 170, 4649-4655 (2003)

Therapeutic effect of intravenous delivery of lipoplexes containing the interferon-beta gene and poly I: poly C in a murine lung metastasis model

Sakurai F., Terada T., Maruyama M., Yamashita F., Takakura Y., and Hashida M.

Cancer Gene Ther., 10, 661-668 (2003)

次世代遺伝子治療薬の開発基盤研究

水口裕之

薬学雑誌, 日本薬学会, 123, 761-771 (2003)

アデノウイルスベクター:最近の進歩

水口裕之, 早川堯夫

分子細胞治療, 2, 200-207 (2003)

遺伝子機能解析のための遺伝子導入ベクター -ウイルスベクターを中心として-

水口裕之, 早川堯夫

蛋白質核酸酵素, 48, 1653-1662 (2003)

21世紀のDDS:発展を担う立場から

橋田充, 水口裕之, 山下富義, 横山昌幸, 原島秀吉, 米谷芳枝, 松村保広, 岡田純一, 五十嵐理慧

Drug Delivery System, 日本DDS学会, 18, 7-20 (2003)

CAR- orαv integrin-binding ablated adenovirus vectors, but not fiber-modified vectors containing RGD peptide, do not change the systemic gene transfer properties in mice

Mizuguchi H., Koizumi N., Hosono T., Ishii-Watabe A., Uchida E., Utoguchi N., Watanabe Y., Hayakawa T.

Gene Ther., 9, 769-776 (2002)

大阪大学大学院 薬学研究科 分子生物学分野 

〒565-0871 大阪府吹田市山田丘1-6 大阪大学 大学院薬学研究科・薬学部 1号館 4階

TEL: 06-6879-8185 FAX: 06-6879-8187

Copyright© Laboratory of Biochemistry and Molecular Biology, Graduate School and School of Pharmaceutical Sciences, Osaka University

directed by Prof. Hiroyuki Mizuguchi

  • 分子生物学分野 | 阪大 | 薬学 | 生化 twitter
bottom of page